Home > Products > CD16 & GD2
> Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (VHH-IgG)
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (VHH-IgG) (CAT#: BSSG-361)
Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (VHH-IgG) is formed by an IgG and two VHH fragments. The VHHs from an anti-GD2 antibody variable domain are respectively connected to the N terminus of the anti-CD16 IgG heavy chains or light chains to form VHH-(H)IgG or VHH-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Melanoma; Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (VHH-IgG) (BSSG-361). Click the button below to contact us or submit your feedback about this product.